Search results
Results from the WOW.Com Content Network
Glucagon-like peptide-1 receptor agonists (GLP-1) drugs are a class of medications used to manage type 2 diabetes and treat obesity. While many drugs in this class are relatively new, researchers ...
The effects that semaglutide has on insulin production and feeling full all start in the brain, Dr. Ania Jastreboff, associate professor at Yale School of Medicine and obesity medicine physician ...
A new study published on August 28 in the journal Diabetes Care reports that while people with type 2 diabetes and prediabetes may be at risk for accelerated brain aging, making healthy lifestyle ...
Diabetic encephalopathy, Diabetes causes brain functional and structural disturbances, known as diabetic encephalopathy. [30] Various mechanisms are proposed, like alterations to the vascular supply of the brain, or changes in cerebral function and structure, including cognitive impairment, cerebral signal conduction, neurotransmission, and ...
Neuroglycopenia is a shortage of glucose (glycopenia) in the brain, usually due to hypoglycemia. Glycopenia affects the function of neurons, and alters brain function and behavior. Prolonged or recurrent neuroglycopenia can result in loss of consciousness, damage to the brain, and eventual death. [1] [2] [3]
Hyperglycemia may be caused by: diabetes, various (non-diabetic) endocrine disorders (insulin resistance and thyroid, adrenal, pancreatic, and pituitary disorders), sepsis and certain infections, intracranial diseases (e.g. encephalitis, brain tumors (especially if near the pituitary gland), brain haemorrhages, and meningitis) (frequently ...
This type of inflammation affects the entire body, including the brain. Chronic low-grade inflammation can contribute to insulin resistance , cause fatigue, and can cause achiness throughout the body.
Symptoms and effects can be mild, moderate or severe, depending on how low the glucose falls and a variety of other factors. It is rare but possible for diabetic hypoglycemia to result in brain damage or death. Indeed, an estimated 2–4% of deaths of people with type 1 diabetes mellitus have been attributed to hypoglycemia. [2] [3]